A whole-protein, powdered formula for the dietary management of Crohn's disease to be used as EEN*, PEN** and/or as part of the CDED†+PEN for induction and maintenance of remission. *EEN - Exclusive Enteral Nutrition/ **PEN - Partial Enteral Nutrition †CDED - Crohn's Disease Exclusion Diet
Modulen® IBD meets the robust guideline criteria for use as a first-line treatment option in active paediatric Crohn's Disease. 8 millions portions/year are used around the world.
Flexibility to mix it with allowed fruits from the Crohn's Disease Exclusion Diet (CDED) and other natural flavours to improve compliance and minimize taste fatigue.
Modulen® IBD was clinically proven to efficiently support management of Crohn's Disease in pediatric and adult patients.
Modulen® IBD supports induction of remission and mucosal healing as well as a positive impact on growth and nutrition status. A cost-effectiveness analysis has shown that over one year treatment, Modulen® IBD could be cost-effective compared to standard ONS.References:1. Van Rheenen et al. The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN 2. Fell et al. Aliment Pharmacol Ther. 2000 Mar;14(3):281-9 3. Berni Canani et al. Dig Liver Dis. 2006 Jun;38(6):381-7. 4. Triantafillidis et al. Annales of Gastroenterology. 2006;19(1):66-71. 5. Borrelli et al. Clin Gastroenterol Hepatol. 2006 Jun;4(6):744-53. 6. Duncan et al. BMC Gastroenterol. 2014 Mar 20;14:50.
Learn more